Cort
Phoenix Rising Founder
- Messages
- 7,392
Twiving XMRV II
XMRV Buzz from the 29th
XMRV Buzz from the 29th
Dr. Rein and Dr. Racaniello on Twiv cont.- Dr. Rein emphasized an important point on sequence variation. He noted that if the sequence you’re looking for is a little different from the published sequence then you can miss it. He said that was an inherent ‘risk’ in PCR and can lead to false negatives. (That risk does not apply to the immunohistochemistry results - which are just coming on CFS now). From that we can conclude that sequence variation is a real question given the newness of XMRV and how little researchers understand it. How antibodies constructed to match up XMRV and other similar viruses should be able to pick it up.
The Big "C" again (and again). They went into a scary scenario - which does not seem to playing out at all - of the water controls researchers use possibly being contaminated from mouse DNA from mouse droppings coming from reservoirs. (No water controls have tested positive….this is not an issue with the XMRV studies). They then went on for a while about contamination possibilities…a millionth of a microliter of mouse DNA (much less than a cell) would be detectable da da da….no need to spell out all the gory details.
The 22Rv1 cell line - Not a Smoking Gun - The 22RV1 cell line has become an area of controversy. Dr. Rein reported that he found that the cell line produces XMRV; ie has become infected with XMRV probably when it was passed through nude mice a couple of decades ago. One of the papers found that XMRV was less diverse than the XMRV in the cell line and therefore concluded that XMRV was probably derived from it. This may have been THE major finding of the four papers - and it seemed very convincing at first but doubts have definitely crept in….Dr. Rein did not agree it was possible to conclude that XMRV was derived from that cell line, and after being initially rocked by the finding, Dr. Racaniello came to the same conclusion. In fact 3 of the 4 commentators - after cheerily espousing on all the dangers of contamination - all agreed that this central finding had been overstated and one of them actually put up a blog post about that. The papers do put a stronger focus on the possibilities of contamination - and the 22RV1 theory could be correct but it has certainly not been proven to be correct or to apply to the WPI’s or other studies. They all agreed that what the field needs is what it is doing; creating strict protocols and sharing samples between labs.
A Definitive Test - XMRV Integration into human DNA. What clinched XMRV for prostate cancer was showing that it was integrated into human DNA. Dr. Rein wanted that finding replicated by other labs and it to be extended to CFS. He noted that Illa Singh is trying very hard to do that; the problem is that it takes a lot of DNA and prostate tumor biopsies do not provide much of that....
What about those Antibodies? They finally got to the big question the patients have been asking - what about those antibodies? Doesn't THAT prove a real infection has occurred? Dr. Rein simply said… another lab needs to replicate those findings. (Dr. Mikovits has reported that Dr. Bagni’s antibody test at the NCI confirms the WPI’s findings; her study has not been published yet.) Of course many labs are developing their own antibody tests and some are finding it and some are not.....
Doesn’t the ability to transfer virus from blood to cells in culture mean virus is there? - This has been a big argument from the WPI. Dr. Rein stated that if XMRV is floating around in the lab then it could get into the samples that way.
How could ME/CFS samples consistently show higher rates of XMRV infection than the controls? Dr. Rein suggested if the ME/CFS samples were handled more it might….but otherwise he didn’t have an answer to that and said he didn’t think ‘we’ have an answer to that.
What is next? Using validated assays…exchanging samples…..using different labs. Dr. Rein does not believe that large-scale case-control human studies are called for - which makes sense; what assay, after all ,are you going to use to test all those people? Instead he called for developing a consensus assay and then moving on - which is essentially what is occurring. He was clear that he believes it’s possible that XMRV was a ‘mistake’ (I think he leans this way given the way his prostate studies have turned out) or that it is is a virus infecting people.
Conclusion - discussing the four Retrovirology papers was never destined to be a fun experience. However, all the researchers agreed the XMRV's options are still very much open and that we still have much more to learn and that several of the ongoing should tell us a lot.
Next Up - an interesting seminar from Dr. Mikovits in Sweden (thanks to Ann!).